← Back to Patent Explorer
US4020094A Expired / Lapsed US ⏱️ 0.0 years remaining

2-Substituted-5-oxo-5H-dibenzo[a,d]cycloheptenes, the salts and esters thereof, having pharmaceutical activity

Assignee: Syntex USA LLC
•
Filing: 1975-03-24
•
Granted: 1977-04-26
•
Expires: 1995-03-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2-Substituted-5-oxo-5H-dibenzo[a,d]cycloheptenes represented by the following formula: <IMAGE> where R' is hydrogen, alkyl having 1 to 12 carbon atoms, or <IMAGE> where n is an integer from 2 to 4, inclusive, and R4 and R5 are independently lower alkyl having 1 to 6 carbon atoms or together R4 and R5 and the nitrogen atom to which they are attached form a heterocyclic ring having 5 or 6 total ring atoms; one of R2 and R3 is hydrogen and the other is hydrogen, methyl, or ethyl, or together R2 and R3 are methylene; and the pharmaceutically acceptable salts thereof. The compounds have anti-inflammatory, analgesic, and antipyretic activities and, accordingly, are useful in the treatment of inflammation, pain and/or pyrexia.

Inventors

  • 👤 Peter H. Nelson
  • 👤 Karl G. Untch

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 04:07
CPC Classifications
C; C07; C07C; C07C65/00; C07C65/32; C07C65/38; C07C51/00; C07C51/41; C07C51/412; C07C59/00; C07C59/40; C07C59/76; C07C59/86; C07C63/00; C07C63/33; C07C63/331; C07C63/66; C07C65/34; C07C65/36

Claims Analysis

Total Claims: 31
Claim 1
Independent Claim 82 words
A compound selected from the group of compounds represented by the formula: ##STR6## where R' is hydrogen, alkyl having 1 to 12 carbon atoms, or ##STR7## n is an integer from 2 through 4, inclusive; R 4 and R 5 are independently lower alkyl having 1 to 6 carbon atoms; one of R 2 and R 3 is hydrogen and the other is hydrogen, methyl, or ethyl, or together R 2 and R 3 are methylene; and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 82 words
A compound selected from the group of compounds represented by the formula: ##STR6## where R' is hydrogen, alkyl having 1 to 12 carbon atoms, or ##STR7## n is an integer from 2 through 4, inclusive; R 4 and R 5 are independently lower alkyl having 1 to 6 carbon atoms; one of R 2 and R 3 is hydrogen and the other is hydrogen, methyl, or ethyl, or together R 2 and R 3 are methylene; and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 9 words
The compound of claim 1 where R' is hydrogen.
Claim 4
Dependent Claim 15 words
The compound of claim 1 where R' is alkyl having 1 to 12 carbon atoms.
Claim 5
Dependent Claim 19 words
The compound of claim 1 where R' is ##STR8## and R 4 and R 5 are independently lower alkyl.
Claim 6
Dependent Claim 14 words
The compound of claim 1 where both R 2 and R 3 are hydrogen.
Claim 7
Dependent Claim 14 words
The compound of claim 1 where said compound of Formula I is (5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)acetic acid.
Claim 8
Dependent Claim 18 words
The compound of claim 1 wherein said compound is the sodium, potassium or calcium salt of 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)acetic acid.
Claim 9
Dependent Claim 14 words
The compound of claim 1 where said compound of Formula I is 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)butyric acid.
Claim 10
Dependent Claim 14 words
The compound of claim 1 where said compound of Formula I is 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)acrylic acid.
Claim 11
Dependent Claim 70 words
A compound selected from the group of compounds represented by the formula: ##STR9## where R' is hydrogen, alkyl having 1 to 12 carbon atoms, or ##STR10## n is an integer from 2 through 4, inclusive; R 4 and R 5 are independently lower alkyl having 1 to 6 carbon atoms; one of R 2 and R 3 is hydrogen and the other is methyl; and the pharmaceutically acceptable salts thereof.
Claim 12
Dependent Claim 70 words
A compound selected from the group of compounds represented by the formula: ##STR9## where R' is hydrogen, alkyl having 1 to 12 carbon atoms, or ##STR10## n is an integer from 2 through 4, inclusive; R 4 and R 5 are independently lower alkyl having 1 to 6 carbon atoms; one of R 2 and R 3 is hydrogen and the other is methyl; and the pharmaceutically acceptable salts thereof.
Claim 13
Dependent Claim 15 words
The compound of claim 10 wherein R' is alkyl having 1 to 12 carbon atoms.
Claim 14
Dependent Claim 19 words
The compound of claim 10 wherein R' is ##STR11## where R 4 and R 5 are independently lower alkyl.
Claim 15
Dependent Claim 2 words
2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 16
Dependent Claim 2 words
2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 17
Dependent Claim 18 words
The compound of claim 10 wherein said compound is the sodium, potassium, or calcium salt of 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 18
Dependent Claim 15 words
The compound of claim 10 wherein said compound is the sodium salt of 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 19
Dependent Claim 11 words
The compound of claim 10 wherein said compound is isopentyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.
Claim 20
Dependent Claim 11 words
The compound of claim 10 wherein said compound is dodecyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.
Claim 21
Dependent Claim 11 words
The compound of claim 10 wherein said compound is β-N,N-dimethylaminoethyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.
Claim 22
Dependent Claim 11 words
The compound of claim 10 wherein said compound is β-N,N-diethylaminoethyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.
Claim 23
Dependent Claim 11 words
The compound of claim 10 wherein said compound is β-N,N-methylethylaminoethyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.
Claim 24
Dependent Claim 3 words
d 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 25
Dependent Claim 3 words
d 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 26
Dependent Claim 19 words
The compound of claim 10 wherein said compound is the sodium, potassium or calcium salt of d 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 27
Dependent Claim 16 words
The compound of claim 10 wherein said compound is the sodium salt of d 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 28
Dependent Claim 15 words
The compound of claim 10 wherein said compound of Formula I is 1 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-1-yl)propionic acid.
Claim 29
Dependent Claim 16 words
The compound of claim 10 wherein said compound is the sodium salt of 1 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionic acid.
Claim 30
Dependent Claim 15 words
A compound selected from the group consisting of 2'-carboxyphenyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate, 2'-carbomethoxyphenyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate, and phenyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.
Claim 31
Dependent Claim 15 words
A compound selected from the group consisting of 2'-carboxyphenyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate, 2'-carbomethoxyphenyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate, and phenyl 2-(5-oxo-5H-dibenzo[a,d]cyclohepten-2-yl)propionate.

References Cited (Backward Citations)

US3256335A Cited
US3468939A Cited
US3624142A Cited
US3600437A Cited
US3641134A Cited
US3803234A Cited
US3780061A Cited
US3933905A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-04-25 1980-10-25 1981-04-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-04-25 1984-10-25 1985-04-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-04-25 1988-10-25 1989-04-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag